News
Positive IND-enabling data on MP0712 targeting DLL3, the most advanced Radio-DARPin program in co-development with Orano Med, entering clinical development in 2025 First preclinical data of novel targ ...
16h
Interesting Engineering on MSNZombies in your skin? US team charts senescent cells to refine anti-aging therapiesSenescent skin cells—sometimes dubbed “zombie cells”—have long posed a paradox. These cells, which stop dividing yet refuse ...
Researchers from Johns Hopkins University have identified three subtypes of senescent skin cells with distinct shapes, ...
Not all zombie skin cells are the same. New research reveals three unique subtypes with different roles in aging and disease, ...
CatalYm today announced the presentation of the first preclinical data demonstrating that the company’s clinical-stage ...
Six posters highlight continued progress across antibody-drug conjugate and T cell engager platforms Novel T cell engager ZW209 demonstrates ...
It's no secret that our waistlines often expand in middle-age, but the problem isn't strictly cosmetic. Belly fat accelerates aging and slows down metabolism, increasing our risk for developing ...
It's no secret that our waistlines often expand in middle age, but the problem isn't strictly cosmetic. Belly fat accelerates ...
Understanding how cells differentiate during early embryonic development is crucial for advancing regenerative medicine and developmental biology. Pluripotent stem cells (PSCs) have been invaluable ...
HAS GRANTED ORPHAN DRUG DESIGNATION IN THE EUROPEAN UNION FOR AB8939 IN THE TREATMENT OF ACUTE MYELOID LEUKEMIA Paris, April 23, 2025, 6.45pm CET AB Science ...
22h
Zacks Investment Research on MSNBuy These 5 Old Economy Stocks With Double-Digit Upside for Near TermU.S. stock markets are witnessing extreme volatility in April due to the imposition of the Trump administration’s “Liberation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results